Stay updated on PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial

Sign up to get notified when there's something new on the PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The clinical trial record for the PDR001 combination study is displayed in place of an access error, with details about the terminated study, its design, eligibility, locations, and outcome measures.
    Difference
    76%
    Check dated 2026-11-08T13:14:23.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0 while the page continued to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T13:58:19.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A banner announces that NIH content may use “Super Intelligence” instead of “Artificial Intelligence” during a terminology transition. The clinical trial record shown below the banner displays a 403 error.
    Difference
    1%
    Check dated 2026-10-25T13:25:52.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now displays revision v3.7.2 instead of v3.7.1; the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T14:45:22.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer revision marker changes from v3.7.0 to v3.7.1 while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T14:34:07.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision: v3.7.0 was added to the page, signaling the latest version of the study record or site update. This change represents a metadata update rather than modification to the study data or visible content.
    Difference
    21%
    Check dated 2026-09-20T20:10:07.000Z thumbnail image

Stay in the know with updates to PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial page.